Alexander Nowak
Stock Analyst at Craig-Hallum
(4.42)
# 367
Out of 4,761 analysts
48
Total ratings
52.78%
Success rate
24.48%
Average return
Main Sectors:
Stocks Rated by Alexander Nowak
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVRX CVRx, Inc. | Maintains: Buy | $20 → $22 | $13.85 | +58.84% | 5 | Jan 17, 2025 | |
| NTRA Natera | Maintains: Buy | $121 → $157 | $162.31 | -3.27% | 4 | Nov 13, 2024 | |
| BVS Bioventus | Maintains: Buy | $12 → $17 | $10.01 | +69.83% | 6 | Sep 27, 2024 | |
| QDEL QuidelOrtho | Upgrades: Buy | $40 → $57 | $40.46 | +40.88% | 6 | Sep 5, 2024 | |
| CELC Celcuity | Assumes: Buy | $25 → $27 | $13.15 | +105.32% | 2 | May 16, 2024 | |
| CDNA CareDx | Upgrades: Buy | $12 → $15 | $22.29 | -32.71% | 3 | May 1, 2024 | |
| DMAC DiaMedica Therapeutics | Assumes: Buy | $8 | $6.51 | +22.89% | 4 | Apr 24, 2024 | |
| AXDX Accelerate Diagnostics | Maintains: Hold | $2 → $1 | $1.19 | -15.97% | 3 | Apr 1, 2024 | |
| LUNG Pulmonx | Initiates: Buy | $18 | $8.96 | +100.89% | 1 | Sep 5, 2023 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $74 → $50 | $31.00 | +61.29% | 2 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $8 | $0.69 | +1,059.42% | 1 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $49.26 | - | 1 | Oct 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.15 | - | 2 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $2.20 | +400.00% | 1 | Jan 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $88 → $110 | $64.92 | +69.44% | 3 | Feb 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | n/a | $0.96 | - | 2 | Jan 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $300 | $3.12 | +9,515.38% | 1 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $7.65 | +266.01% | 1 | Aug 31, 2020 |
CVRx, Inc.
Jan 17, 2025
Maintains: Buy
Price Target: $20 → $22
Current: $13.85
Upside: +58.84%
Natera
Nov 13, 2024
Maintains: Buy
Price Target: $121 → $157
Current: $162.31
Upside: -3.27%
Bioventus
Sep 27, 2024
Maintains: Buy
Price Target: $12 → $17
Current: $10.01
Upside: +69.83%
QuidelOrtho
Sep 5, 2024
Upgrades: Buy
Price Target: $40 → $57
Current: $40.46
Upside: +40.88%
Celcuity
May 16, 2024
Assumes: Buy
Price Target: $25 → $27
Current: $13.15
Upside: +105.32%
CareDx
May 1, 2024
Upgrades: Buy
Price Target: $12 → $15
Current: $22.29
Upside: -32.71%
DiaMedica Therapeutics
Apr 24, 2024
Assumes: Buy
Price Target: $8
Current: $6.51
Upside: +22.89%
Accelerate Diagnostics
Apr 1, 2024
Maintains: Hold
Price Target: $2 → $1
Current: $1.19
Upside: -15.97%
Pulmonx
Sep 5, 2023
Initiates: Buy
Price Target: $18
Current: $8.96
Upside: +100.89%
Tandem Diabetes Care
Jun 13, 2023
Maintains: Buy
Price Target: $74 → $50
Current: $31.00
Upside: +61.29%
May 12, 2023
Maintains: Buy
Price Target: $14 → $8
Current: $0.69
Upside: +1,059.42%
Oct 19, 2022
Downgrades: Hold
Price Target: n/a
Current: $49.26
Upside: -
Mar 28, 2022
Downgrades: Hold
Price Target: n/a
Current: $1.15
Upside: -
Jan 5, 2022
Initiates: Buy
Price Target: $11
Current: $2.20
Upside: +400.00%
Feb 3, 2021
Maintains: Buy
Price Target: $88 → $110
Current: $64.92
Upside: +69.44%
Jan 20, 2021
Downgrades: Sell
Price Target: n/a
Current: $0.96
Upside: -
Jan 11, 2021
Initiates: Buy
Price Target: $300
Current: $3.12
Upside: +9,515.38%
Aug 31, 2020
Initiates: Buy
Price Target: $28
Current: $7.65
Upside: +266.01%